Correlation Between BioLife Sciences and Predictive Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioLife Sciences and Predictive Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioLife Sciences and Predictive Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioLife Sciences and Predictive Oncology, you can compare the effects of market volatilities on BioLife Sciences and Predictive Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioLife Sciences with a short position of Predictive Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioLife Sciences and Predictive Oncology.

Diversification Opportunities for BioLife Sciences and Predictive Oncology

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between BioLife and Predictive is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding BioLife Sciences and Predictive Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Predictive Oncology and BioLife Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioLife Sciences are associated (or correlated) with Predictive Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Predictive Oncology has no effect on the direction of BioLife Sciences i.e., BioLife Sciences and Predictive Oncology go up and down completely randomly.

Pair Corralation between BioLife Sciences and Predictive Oncology

If you would invest  139.00  in Predictive Oncology on November 27, 2024 and sell it today you would earn a total of  1.00  from holding Predictive Oncology or generate 0.72% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

BioLife Sciences  vs.  Predictive Oncology

 Performance 
       Timeline  
BioLife Sciences 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days BioLife Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, BioLife Sciences is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
Predictive Oncology 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Predictive Oncology are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite fairly conflicting basic indicators, Predictive Oncology demonstrated solid returns over the last few months and may actually be approaching a breakup point.

BioLife Sciences and Predictive Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioLife Sciences and Predictive Oncology

The main advantage of trading using opposite BioLife Sciences and Predictive Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioLife Sciences position performs unexpectedly, Predictive Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Predictive Oncology will offset losses from the drop in Predictive Oncology's long position.
The idea behind BioLife Sciences and Predictive Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data